On February 2022, WHO released the evidence-based guideline on control and elimination of human schistosomiasis, with aims to guide the elimination of schistosomiasis as a public health problem in disease-endemic countries by 2030 and promote the interruption of schistosomiasis transmission across the world. Based on the One Health concept, six evidence-based recommendations were proposed in this guideline. This article aims to analyze the feasibility of key aspects of this guideline in Chinese national schistosomiasis control program and illustrate the significance to guide the future actions for Chinese national schistosomiasis control program. Currently, the One Health concept has been embodied in the Chinese national schistosomiasis control program. Based on this new WHO guideline, the following recommendations are proposed for the national schistosomiasis control program of China: (1) improving the systematic framework building, facilitating the agreement of the cross-sectoral consensus, and building a high-level leadership group; (2) optimizing the current human and livestock treatments in the national schistosomiasis control program of China; (3) developing highly sensitive and specific diagnostics and the framework for verifying elimination of schistosomiasis; (4) accelerating the progress towards elimination of schistosomiasis and other parasitic diseases through integrating the national control programs for other parasitic diseases.
［摘要］ 2022 年 2 月, WHO 基于循证医学框架发布了《WHO控制和消除人体血吸虫病指南》 (以下简称 WHO 新指南), 以指导血吸虫病流行国家和地区控制和消除这一公共卫生问题、促进阻断血吸虫病传播。WHO 新指南以全健康理念为 基础, 提出了 6 项核心建议。本文旨在分析 WHO 新指南中的关键内容对我国血吸虫病防控工作的适用性, 阐释其对我 国血吸虫病防治工作后续发展的指导意义。目前, 我国血吸虫病防控体系在实施层面上已基本体现全健康理念及其组 成部分。基于WHO新指南, 针对我国血吸虫病防治工作提出如下建议：加强系统性框架建设, 推动跨部门共识的形成, 建立高级别领导小组; 优化现阶段我国血吸虫病防治策略中的人畜治疗措施; 开发高敏感度和高特异度的检测工具和消 除验证框架; 通过整合其他寄生虫病防治项目, 进一步推动血吸虫病和其他寄生虫病防控工作。.
Keywords: Elimination; Guideline; One Health; Schistosomiasis.